Forward News

FDA Approves Contrast Dye for Focal Liver Disease

The first organ-specific MRI contrast agent to be approved in the U.S. for over a decade is expected to be marketed this summer under the brand name "Eovist."
From:   (your name)    (your email address) Forward To: 1. 2. 3. 4. 5.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED